Assessing and Improving Organizational Readiness to Implement Substance Use Disorder Treatment in Primary Care

Findings from the SUMMIT Study

Published in: BMC Family Practice, Volume 18, Number 1 (December 2017), Page 107. doi: 10.1186/s12875-017-0673-6

Posted on RAND.org on February 13, 2018

by Allison J. Ober, Katherine E. Watkins, Sarah B. Hunter, Brett Ewing, Karen Lamp, Mimi Lind, Kirsten Becker, Keith G. Heinzerling, Karen Chan Osilla, Allison Diamant, Claude Messan Setodji

Read More

Access further information on this document at BMC Family Practice

This article was published outside of RAND. The full text of the article can be found at the link above.

Millions of people with substance use disorders (SUDs) need, but do not receive, treatment. Delivering SUD treatment in primary care settings could increase access to treatment because most people visit their primary care doctors at least once a year, but evidence-based SUD treatments are underutilized in primary care settings. We used an organizational readiness intervention comprised of a cluster of implementation strategies to prepare a federally qualified health center to deliver SUD screening and evidence-based treatments (extended-release injectable naltrexone (XR-NTX) for alcohol use disorders, buprenorphine/naloxone (BUP/NX) for opioid use disorders and a brief motivational interviewing/cognitive behavioral -based psychotherapy for both disorders). This article reports the effects of the intervention on key implementation outcomes.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.